Karolinska Development Appoints Fredrik Järrsten as Chief Financial Officer
(Thomson Reuters ONE) -
STOCKHOLM - August 29, 2017 - Karolinska Development AB (Nasdaq Stockholm: KDEV)
today announces that it has appointed Fredrik Järrsten as Chief Financial
Officer. Mr Järrsten, will join the Company towards the end of 2017. Mr Järrsten
will replace Christian Tange who, after 4 years with Karolinska Development, has
decided to pursue other opportunities. Mr Tange will remain with the Company
until after Mr Järrsten's arrival to ensure a smooth and orderly hand over
period.
Fredrik Järrsten is an experienced financial and business development
executive. He will join Karolinska Development from Bactiguard Holding AB, a
public Swedish Medtech company where he is Chief Financial Officer and Business
Development director. At Bactiguard he, among other things, led the company's
IPO on Nasdaq Stockholm in June 2014. Prior to joining Bactiguard in 2014,
Fredrik was Director Business Development, including M&A, at Aleris, one of
Scandinavia's leading private healthcare companies. While at Aleris, Fredrik
concluded 30 acquisitions and 2 disposals which contributed significantly to the
company's growth. Before joining Aleris in 2006, Fredrik was an Investment
Manager at the private equity company, Litorina Kapital for 7 years, where he
was on the Boards of 6 investee companies.
Viktor Drvota, CEO, comments: "I am very pleased that Fredrik has decided to
join Karolinska Development. His broad financial knowledge both as a CFO and an
investor, as well as his significant business development and M&A experience,
will be vital as we work to generate exits from our investee companies. We
believe we have multiple potential exit opportunities in the next twelve months
which, if achieved, would crystalize significant value for our shareholders.
I would also like to thank Christian for his hard work over the last four years,
a period of enormous change for Karolinska Development, and I wish him success
with his future plans. I am pleased that he has agreed to work alongside Fredrik
to ensure a smooth transition period."
For further information, please contact:
Viktor Drvota, CEO, Karolinska Development AB
Phone: +46 73 982 52 02, e-mail: viktor.drvota(at)karolinskadevelopment.com
Christian Tange, CFO, Karolinska Development AB
Phone: +46 73 712 14 30, e-mail: christian.tange(at)karolinskadevelopment.com
David Dible/Mark Swallow/Pip Batty, Citigate Dewe Rogerson
Phone: +44 20 7638 9571; e-mail: KDev(at)citigatedr.co.uk
About Karolinska Development AB
Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences
investment company. The company focuses on identifying breakthrough medical
innovations in the Nordic region that are developed by entrepreneurs and
leadership teams. The Company invests in the creation and growth of companies
that advance these assets into commercial products that are designed to make a
difference to patients' lives while providing an attractive return on investment
to shareholders.
Karolinska Development has access to world-class medical innovations at the
Karolinska Institutet and other leading universities and research institutes in
the Nordic region. The Company aims to build companies around scientists who are
leaders in their fields, supported by experienced management teams and advisers,
and co-funded by specialist international investors, to provide the greatest
chance of success.
Karolinska Development has established a portfolio of nine companies targeting
opportunities in innovative treatment for life-threatening or serious
debilitating diseases.
The Company is led by an entrepreneurial team of investment professionals with a
proven track record as company builders and with access to a strong global
network.
For more information, please visit www.karolinskadevelopment.com
This information is information that Karolinska Development AB (publ) (Nasdaq
Stockholm: KDEV) is obliged to make public pursuant to the EU Market Abuse
Regulation. The information was submitted for publication, through the agency of
Viktor Drvota, at 5.45 pm CEST on August 29, 2017
PR KD CFO (ENG):
http://hugin.info/143071/R/2130001/813711.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Karolinska Development AB (publ) via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 29.08.2017 - 17:45 Uhr
Sprache: Deutsch
News-ID 558175
Anzahl Zeichen: 5146
contact information:
Town:
Solna
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 372 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Karolinska Development Appoints Fredrik Järrsten as Chief Financial Officer"
steht unter der journalistisch-redaktionellen Verantwortung von
Karolinska Development AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
